OpenAI has acquired Orchestra Bio, a startup building AI agents for pharmaceutical development workflows. The deal brings Orchestra Bio's team and technology into Rosalind , OpenAI's life sciences AI ecosystem , with the stated goal of streamlining operations that connect research findings, plan...
Source: [Dev.to](https://dev.to/alifar/openai-acquires-orchestra-bio-to-expand-rosalind-into-drug-development-operations-mad)